MedPath

Comparison of alendronate and teriparatide for the bone mineral density around implant after total hip arthroplasty

Not Applicable
Completed
Conditions
cases after primary total hip arthroplasty
Registration Number
JPRN-UMIN000016158
Lead Sponsor
Yokohama City University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

cases of malignant tumor cases with difficulty of one year follow-up

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of bone mineral density in teriparatide treatment, alendronate treatment, and control group
Secondary Outcome Measures
NameTimeMethod
Change of bone formation markers in teriparatide treatment, alendronate treatment, and control group
© Copyright 2025. All Rights Reserved by MedPath